AstraZeneca has made a preliminary approach to Gilead Sciences about a potential merger, according to Bloomberg.
AstraZeneca informally contacted Gilead last month to gauge its interest in a possible tie-up asking not to be identified because the details are private, reports Bloomberg. AstraZenec